Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
What is lemborexant?Lemborexant (generic name: lemborexant) is a prescription medicine designed specifically for adult insomnia patients aged 18 and older. Insomnia presents as dif···【more】
Article source：Captain MedicineRelease date：2026-06-26Recommended：507
Lucius Version of Regorafenib: Dosage and Administration, Indications, PrecautionsIndicationsRegorafenib is a kinase inhibitor indicated for the treatment of patients with metastat···【more】
Article source：Captain MedicineRelease date：2025-12-09Recommended：570
Lucius Version of Belzutifan: Dosage and Administration, Indications, PrecautionsIndicationsBelzutifan is a hypoxia-inducible factor inhibitor indicated for:Von Hippel-Lindau (VHL)···【more】
Article source：Captain MedicineRelease date：2025-12-04Recommended：593
LuciusVersionofRibociclib:DosageandAdministration,Indications,PrecautionsIndicationIndicated for the treatment of adult patients with hormone receptor (HR)-positive, human epiderma···【more】
Article source：Captain MedicineRelease date：2025-12-04Recommended：651
During treatment with LuciDarax(Daraxonrasib), please have blood counts and biochemistry tests reviewed as directed by your physician. If severe rash, an increase in bowel movement···【more】
Article source：Captain MedicineRelease date：2026-10-14Recommended：157
Before using LuciDarax(Daraxonrasib), prophylactic skin care is required. Prepare topical glucocorticoids (to be applied to the face and chest as directed by the physician), a whol···【more】
Article source：Captain MedicineRelease date：2026-10-14Recommended：157
For treatment of H3 K27M-mutant diffuse midline glioma progressing after prior therapy in adults and children ≥1 year.【more】
Article source：Captain MedicineRelease date：2026-10-13Recommended：9
The recommended dose of LuciDarax(Daraxonrasib) is 300 mg, orally, once daily, until disease progression or unacceptable toxicity. LuciDarax(Daraxonrasib) is available only as 100 ···【more】
Article source：Captain MedicineRelease date：2026-10-12Recommended：182
LuciDarax(Daraxonrasib) is an oral pan-RAS inhibitor for adults with metastatic pancreatic adenocarcinoma whose disease has failed at least one prior line of systemic therapy or wh···【more】
Article source：Captain MedicineRelease date：2026-10-12Recommended：240
During treatment with LuciDarax(Daraxonrasib), please follow your doctor's instructions for follow-up visits and imaging assessments. Do not increase the dose or stop the drug ···【more】
Article source：Captain MedicineRelease date：2026-10-10Recommended：248
LuciDarax(Daraxonrasib) was approved by the U.S. FDA on August 26, 2026, under the brand name RASONQUE. It is the first oral targeted drug approved in the United States that direct···【more】
Article source：Captain MedicineRelease date：2026-10-10Recommended：267
Daraxonrasib for adults with metastatic pancreatic adenocarcinoma who have had ≥1 prior therapy or cannot receive combination anticancer therapy.【more】
Article source：Captain MedicineRelease date：2026-10-10Recommended：80
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：8522025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：10482024-09-07
Recently, Lao Lucius Pharmaceutical (Lucius Pharmaceuticals) issued a solemn statement regarding cou···【more】
Recommended：2882026-10-10
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended：4002026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended：5922026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended：5552026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended：4502026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended：6052026-31-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
